DV
Dividend Vision

MIRM — Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc. (MIRM)

Total return is 661.8% over the past 7.1 years, 474.1 points ahead of SPY at 187.7%. Its deepest 1-year drawdown was 26.8%.

MIRM is a healthcare equity stock that operates in the pharmaceutical sector. As a single-stock holding rather than a diversified fund, it does not have a traditional distribution rate, expense ratio, or fund-level characteristics typical of ETFs. This security appeals primarily to investors seeking direct exposure to a specific pharmaceutical company rather than those pursuing broad dividend income strategies.

MIRM key facts

Asset type
Stock
Asset class
Equity
Inception date
07/18/2019
Distribution frequency
None
Last close
$100.64
Market cap
$6,137,150,976
Average volume
503800.0
Beta
0.507
Payout ratio
0.0
Forward P/E
39.6825
EPS
$-14.35